Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis

BACKGROUND: Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis. AIM: To report efficacy and infection rates in patients receiving tofacitinib induction treatment, by baseline corticosteroid status. METHODS: We evaluated efficacy and safety data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichtenstein, Gary R., Cohen, Benjamin L., Salese, Leonardo, Modesto, Irene, Wang, Wenjin, Chan, Gary, Ahmed, Haytham Mohamed, Su, Chinyu, Peyrin-Biroulet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899108/
https://www.ncbi.nlm.nih.gov/pubmed/36739367
http://dx.doi.org/10.1007/s10620-022-07794-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899108/
https://www.ncbi.nlm.nih.gov/pubmed/36739367
http://dx.doi.org/10.1007/s10620-022-07794-0

Ejemplares similares